Brand A - Search Results

1

Acute Management of Hemostasis in Patients With Neurological Injury.

Baharoglu MI, Brand A, Koopman MM, Vermeulen M, Roos YBWEM. Baharoglu MI, et al. Among authors: brand a. Transfus Med Rev. 2017 Oct;31(4):236-244. doi: 10.1016/j.tmrv.2017.07.002. Epub 2017 Jul 13. Transfus Med Rev. 2017. PMID: 28802751 Review.

2

PATCH: platelet transfusion in cerebral haemorrhage: study protocol for a multicentre, randomised, controlled trial.

de Gans K, de Haan RJ, Majoie CB, Koopman MM, Brand A, Dijkgraaf MG, Vermeulen M, Roos YB; PATCH Investigators. de Gans K, et al. Among authors: brand a. BMC Neurol. 2010 Mar 18;10:19. doi: 10.1186/1471-2377-10-19. BMC Neurol. 2010. PMID: 20298539 Free PMC article. Clinical Trial.

3

Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial.

Baharoglu MI, Cordonnier C, Al-Shahi Salman R, de Gans K, Koopman MM, Brand A, Majoie CB, Beenen LF, Marquering HA, Vermeulen M, Nederkoorn PJ, de Haan RJ, Roos YB; PATCH Investigators. Baharoglu MI, et al. Among authors: brand a. Lancet. 2016 Jun 25;387(10038):2605-2613. doi: 10.1016/S0140-6736(16)30392-0. Epub 2016 May 10. Lancet. 2016. PMID: 27178479 Free article. Clinical Trial.

4

Intravenous immunoglobulin treatment in hematological diseases.

Otten A, Bossuyt PM, Vermeulen M, Brand A. Otten A, et al. Among authors: brand a. Eur J Haematol. 1998 Feb;60(2):73-85. doi: 10.1111/j.1600-0609.1998.tb01002.x. Eur J Haematol. 1998. PMID: 9508347 Review.

5

Clinical significance of antibodies against peripheral nerve tissue in inflammatory polyneuropathy.

van Doorn PA, Brand A, Vermeulen M. van Doorn PA, et al. Among authors: brand a. Neurology. 1987 Nov;37(11):1798-802. doi: 10.1212/wnl.37.11.1798. Neurology. 1987. PMID: 3670618

6

Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study.

Vermeulen M, van Doorn PA, Brand A, Strengers PF, Jennekens FG, Busch HF. Vermeulen M, et al. Among authors: brand a. J Neurol Neurosurg Psychiatry. 1993 Jan;56(1):36-9. doi: 10.1136/jnnp.56.1.36. J Neurol Neurosurg Psychiatry. 1993. PMID: 8429321 Free PMC article. Clinical Trial.

7

Autoimmunoreactivity to Schwann cells in patients with inflammatory neuropathies.

Kwa MS, van Schaik IN, De Jonge RR, Brand A, Kalaydjieva L, van Belzen N, Vermeulen M, Baas F. Kwa MS, et al. Among authors: brand a. Brain. 2003 Feb;126(Pt 2):361-75. doi: 10.1093/brain/awg030. Brain. 2003. PMID: 12538403

8

Anti-neuroblastoma cell line antibodies in inflammatory demyelinating polyneuropathy: inhibition in vitro and in vivo by IV immunoglobulin.

van Doorn PA, Brand A, Vermeulen M. van Doorn PA, et al. Among authors: brand a. Neurology. 1988 Oct;38(10):1592-5. doi: 10.1212/wnl.38.10.1592. Neurology. 1988. PMID: 2843794

9

Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy. Clinical and laboratory characteristics associated with improvement.

van Doorn PA, Vermeulen M, Brand A, Mulder PG, Busch HF. van Doorn PA, et al. Among authors: brand a. Arch Neurol. 1991 Feb;48(2):217-20. doi: 10.1001/archneur.1991.00530140113024. Arch Neurol. 1991. PMID: 1847041

10

Immunomodulation and remyelination: two aspects of human polyclonal immunoglobulin treatment in immune mediated neuropathies?

van Schaik IN, Vermeulen M, Brand A. van Schaik IN, et al. Among authors: brand a. Mult Scler. 1997 Apr;3(2):98-104. doi: 10.1177/135245859700300208. Mult Scler. 1997. PMID: 9291162 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,362 results

Search Page

Filters